Skip to content

Sana Biotechnology SANA Increase Decrease In Operating Lease Right Of Use Assets And Liabilities

Increase Decrease In Operating Lease Right Of Use Assets And Liabilities at other companies

SkyWest logo
SkyWestSKYW
-$1.45M-676%
EverQuote logo
EverQuoteEVER
-$298K-11.6%
Advance Auto Parts logo
Advance Auto PartsAAP
-$24M+52.0%
Impinj, Inc. logo
Impinj, Inc.PI
-$390K+40.3%
Adaptive Biotechnologies logo
Adaptive BiotechnologiesADPT
-$2.6M-27.8%
V.F. Corporation logo
V.F. CorporationVFC
$87.49M-3.8%

Other financials

Income statement

See full
Operating income-$48.6M+4.0%
Net income-$47.2M+4.4%
EPS (diluted)-$0.17+19.0%

Balance sheet

See full
Cash & equivalents$83.8M-12.8%
Total debt$75.3M-17.5%
Total equity$119.2M-43.0%
Total assets$373.6M-16.1%

Cash flow

See full
Operating cash flow-$37.4M+23.2%
CapEx$288.0K+112%
Free cash flow-$37.7M+22.8%

Valuation

See full
Market cap$912.8M+55.1%
Enterprise value$904.32M+54.9%

Returns & leverage

See full
Return on equity-147.4%-2,468pp
Debt / equity0.6×+0.2×
Current ratio1.3×-2.1×

Where this comes from

Reported directly by Sana Biotechnology in its filing.

Tagged under the XBRL concept sana:IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities.

The official record: Sana Biotechnology’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sana Biotechnology's increase decrease in operating lease right of use assets and liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sana Biotechnology's increase decrease in operating lease right of use assets and liabilities?
Sana Biotechnology (SANA) reported increase decrease in operating lease right of use assets and liabilities of $1.5M in Q1 2026.
How has Sana Biotechnology's increase decrease in operating lease right of use assets and liabilities changed year-over-year?
Sana Biotechnology's increase decrease in operating lease right of use assets and liabilities increased by 267.9% year-over-year, from -$891K to $1.5M.
What is the long-term trend for Sana Biotechnology's increase decrease in operating lease right of use assets and liabilities?
Over 2 years (2023 to 2025), Sana Biotechnology's increase decrease in operating lease right of use assets and liabilities has grown at a -47.7% compound annual growth rate (CAGR), from -$10.96M to $3M.
What does increase decrease in operating lease right of use assets and liabilities mean?
This metric reflects the net change in the balance sheet value of right-of-use assets and corresponding lease liabilities arising from operating lease activities. It captures the impact of new lease agreements, modifications, or the amortization of existing lease arrangements on the company's operating cash flow. Monitoring this helps investors understand the company's commitment to physical infrastructure and office space requirements.